Miller Mary sold ACRV
October 5, 2026 · Form 4 insider transaction
Miller Mary sold 294 shares of Acrivon Therapeutics, Inc. at $1.99 per share, a transaction worth $585.06. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
294
Price
$1.99
Total value
$585.06
InsiderMiller Mary
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 5, 2026
Filing dateOctober 7, 2026
Shares owned after81,715
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares sold automatically to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.; The price reported in Column 4 above reflects the weighted average price of 337 shares sold by a broker on October 5, 2026, to satisfy the payment of withholding tax liability of a group of employees of the Issuer, including the reporting person. The proceeds of all such sales were allocated to the employees, including the reporting person, on a pro rata basis.